For example, Bartkova et al. observed higher CHK2 activation in the early TNM stages of bladder cancer [32], while Kshirsagar et al. found elevated expression of pCHK2-Thr68 in high-grade serous ovarian carcinoma [33]. The gene discussed is CHEK2; the disease is ovarian serous carcinoma.